Christopher Rowe, University of Melbourne - part of the CMIC/WEISS joint seminar series

Christopher Rowe, Director of the NNIDR funded Australian Dementia Network

Title: Molecular Neuroimaging of Dementia: Clinical and Research Application

Short bio:
Professor Christopher Rowe is a nuclear medicine physician and neurologist, Director of the NNIDR funded Australian Dementia Network, Director of Molecular Imaging Research at Austin Health, Professorial Fellow University of Melbourne and a NHMRC Practitioner Fellow. His research focus is molecular imaging of neurodegenerative diseases, particularly AD, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions. He is in the 2018 Highly Cited Researcher list of the top 1% world-wide for neuroscience and has received the 2011 US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the 2016 Christopher Clark Award for advancing human amyloid imaging. His current work is focussed on tau imaging with F-18 MK6240 and MAO-B imaging as a marker of reactive astrocystosis.